Clinical trial
NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions
NCT01783600 is registered in ClinicalTrials.gov with Flanders Medical Research Program as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions
- Lead sponsor
- Flanders Medical Research Program
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- March 31, 2016
- Enrollment
- 100 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.